Lonza Group (OTCMKTS:LZAGY) Stock Rating Upgraded by The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Lonza Group (OTCMKTS:LZAGY) to a strong-buy rating in a report issued on Wednesday morning, Zacks.com reports.

Separately, Berenberg Bank raised shares of Lonza Group to a strong-buy rating in a research report on Sunday, June 23rd.

Lonza Group Trading Up 1.0 %

LZAGY opened at $61.37 on Wednesday. The business’s 50-day simple moving average is $63.79 and its 200 day simple moving average is $59.56. Lonza Group has a 52-week low of $34.19 and a 52-week high of $67.00.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.